Ana R. Stankovic

903 total citations
8 papers, 600 citations indexed

About

Ana R. Stankovic is a scholar working on Organic Chemistry, Nephrology and Pathology and Forensic Medicine. According to data from OpenAlex, Ana R. Stankovic has authored 8 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Organic Chemistry, 2 papers in Nephrology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Ana R. Stankovic's work include Asymmetric Synthesis and Catalysis (2 papers), Heavy metals in environment (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Ana R. Stankovic is often cited by papers focused on Asymmetric Synthesis and Catalysis (2 papers), Heavy metals in environment (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Ana R. Stankovic collaborates with scholars based in United States, Serbia and Montenegro. Ana R. Stankovic's co-authors include Slavka Stanković, Viresh H. Rawal, Predrag Kalaba, Avinash N. Thadani, Nobuaki Waizumi, Mihajlo Jović, Danijela Joksimović, Norman K. Hollenberg, Naomi D.L. Fisher and Ajay Singh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and SHILAP Revista de lepidopterología.

In The Last Decade

Ana R. Stankovic

8 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana R. Stankovic United States 7 214 185 164 79 49 8 600
M. M. Sidky Egypt 13 440 2.1× 244 1.3× 273 1.7× 54 0.7× 38 0.8× 79 1.0k
Beatriz Bicalho Canada 18 104 0.5× 303 1.6× 189 1.2× 142 1.8× 32 0.7× 27 990
Xiangyang Qin China 14 101 0.5× 390 2.1× 108 0.7× 200 2.5× 179 3.7× 48 1.1k
Kunio Shiraishi Japan 19 124 0.6× 61 0.3× 60 0.4× 131 1.7× 179 3.7× 95 1.2k
Sandro Spezia Italy 16 91 0.4× 206 1.1× 163 1.0× 142 1.8× 54 1.1× 26 801
Vibor Roje Croatia 18 117 0.5× 331 1.8× 183 1.1× 61 0.8× 81 1.7× 37 878
Mengmeng Xu China 14 163 0.8× 83 0.4× 189 1.2× 121 1.5× 15 0.3× 35 586
Dmitrii M. Mazur Russia 16 120 0.6× 72 0.4× 196 1.2× 61 0.8× 19 0.4× 53 598
Alan R. Oyler United States 16 166 0.8× 87 0.5× 159 1.0× 189 2.4× 21 0.4× 32 878
Shino Homma‐Takeda Japan 18 65 0.3× 49 0.3× 283 1.7× 198 2.5× 167 3.4× 66 962

Countries citing papers authored by Ana R. Stankovic

Since Specialization
Citations

This map shows the geographic impact of Ana R. Stankovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana R. Stankovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana R. Stankovic more than expected).

Fields of papers citing papers by Ana R. Stankovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana R. Stankovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana R. Stankovic. The network helps show where Ana R. Stankovic may publish in the future.

Co-authorship network of co-authors of Ana R. Stankovic

This figure shows the co-authorship network connecting the top 25 collaborators of Ana R. Stankovic. A scholar is included among the top collaborators of Ana R. Stankovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana R. Stankovic. Ana R. Stankovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Stankovic, Ana R., et al.. (2016). Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series. BMC Nephrology. 17(1). 37–37. 38 indexed citations
2.
Stankovic, Ana R., et al.. (2013). Cancer of Unknown Primary Site Syndrome‐CUP Syndrome - Diagnostic and Therapeutical Dillemas. SHILAP Revista de lepidopterología. 31(2). 87–94. 3 indexed citations
3.
Stanković, Slavka, Predrag Kalaba, & Ana R. Stankovic. (2013). Biota as toxic metal indicators. Environmental Chemistry Letters. 12(1). 63–84. 194 indexed citations
5.
Vadivel, Nidyanandh, Ana R. Stankovic, H. G. Rennke, & Ajay Singh. (2006). Accepting prospective kidney donors with asymptomatic urinary abnormalities: Are we shooting in the dark?. Kidney International. 71(2). 173–177. 8 indexed citations
6.
Stankovic, Ana R., Naomi D.L. Fisher, & Norman K. Hollenberg. (2006). Prorenin and Angiotensin-Dependent Renal Vasoconstriction in Type 1 and Type 2 Diabetes. Journal of the American Society of Nephrology. 17(12). 3293–3299. 23 indexed citations
7.
Thadani, Avinash N., Ana R. Stankovic, & Viresh H. Rawal. (2004). Enantioselective Diels–Alder reactions catalyzed by hydrogen bonding. Proceedings of the National Academy of Sciences. 101(16). 5846–5850. 185 indexed citations
8.
Waizumi, Nobuaki, Ana R. Stankovic, & Viresh H. Rawal. (2003). A General Strategy to Elisabethane Diterpenes:  Stereocontrolled Synthesis of Elisapterosin B via Oxidative Cyclization of an Elisabethin Precursor. Journal of the American Chemical Society. 125(43). 13022–13023. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026